Evidence map›Paper›PMID 25900663›Full record

ArticleCellular and molecular life sciences : CMLS2015

Quantification of cell fusion events human breast cancer cells and breast epithelial cells using a Cre-LoxP-based double fluorescence reporter system.

Marieke Mohr, Songül Tosun, Wolfgang H Arnold, Frank Edenhofer, Kurt S Zänker, Thomas Dittmar

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 32 citations in OpenAlex.

  1. Implications of Heterotypic Cell Fusion in Cancer.Advances in experimental medicine and biology · 2026
    Review
  2. How Do Cancer Cells Fuse and Why?Advances in experimental medicine and biology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. The Hallmarks of Circulating Hybrid Cells.Results and problems in cell differentiation · 2024
    Review
  7. Cell Fusion and Syncytia Formation in Cancer.Results and problems in cell differentiation · 2024
    Review
  8. Mechanisms of Cell Fusion in Cancer.Results and problems in cell differentiation · 2024
    Review
  9. Extracellular Events Involved in Cancer Cell-Cell Fusion.International journal of molecular sciences · 2022
    Review
  10. Review
  11. Generation of Cancer Stem/Initiating Cells by Cell-Cell Fusion.International journal of molecular sciences · 2022
    Review
  12. Tumor Hybrid Cells: Nature and Biological Significance.Frontiers in cell and developmental biology · 2022
    Review
  13. The Role of MSCs and Cell Fusion in Tissue Regeneration.International journal of molecular sciences · 2021
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Recent Advances in Studies of Skin Color and Skin Cancer.The Yale journal of biology and medicine · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Marieke MohrInstitute of Immunology and Experimental Oncology, Center for Biomedical Education and Research, Witten/Herdecke University, Stockumer Str. 10, 58448, Witten, Germany.
Songül TosunInstitute of Immunology and Experimental Oncology, Center for Biomedical Education and Research, Witten/Herdecke University, Stockumer Str. 10, 58448, Witten, Germany.
Wolfgang H ArnoldDepartment of Biological and Material Sciences in Dentistry, School of Dentistry, Faculty of Health, Witten/Herdecke University, Witten, Germany.
Frank EdenhoferStem Cell and Regenerative Medicine Group, Institute of Anatomy and Cell Biology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
Kurt S ZänkerInstitute of Immunology and Experimental Oncology, Center for Biomedical Education and Research, Witten/Herdecke University, Stockumer Str. 10, 58448, Witten, Germany.
Thomas DittmarInstitute of Immunology and Experimental Oncology, Center for Biomedical Education and Research, Witten/Herdecke University, Stockumer Str. 10, 58448, Witten, Germany. thomas.dittmar@uni-wh.de.
Witten/Herdecke University · DEUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biological phenomenon of cell fusion plays an important role in several physiological processes, like fertilization, placentation, or wound healing/tissue regeneration, as well as pathophysiological processes, such as cancer. Despite this fact, considerably less is still known about the factors and conditions that will induce the merging of two plasma membranes. Inflammation and proliferation has been suggested as a positive trigger for cell fusion, but it remains unclear, which of the factor(s) of the inflamed microenvironment are being involved. To clarify this we developed a reliable assay to quantify the in vitro fusion frequency of cells using a fluorescence double reporter vector (pFDR) containing a LoxP-flanked HcRed/DsRed expression cassette followed by an EGFP expression cassette. Because cell fusion has been implicated in cancer progression four human breast cancer cell lines were stably transfected with a pFDR vector and were co-cultured with the stably Cre-expressing human breast epithelial cell line. Cell fusion is associated with a Cre-mediated recombination resulting in induction of EGFP expression in hybrid cells, which can be quantified by flow cytometry. By testing a panel of different cytokines, chemokines, growth factors and other compounds, including exosomes, under normoxic and hypoxic conditions our data indicate that the proinflammatory cytokine TNF-α together with hypoxia is a strong inducer of cell fusion in human MDA-MB-435 and MDA-MB-231 breast cancer cells.

Indexed as

Blotting, WesternBreast NeoplasmsCell FusionCell HypoxiaCell Line, TumorFemaleFlow CytometryGenetic VectorsGreen Fluorescent ProteinsHumansIntegrasesMammary Glands, HumanMicroscopy, Electron, ScanningTumor Necrosis Factor-alphaCre recombinaseenhanced green fluorescent proteinGreen Fluorescent ProteinsIntegrasesTumor Necrosis Factor-alphaBreast cancerCell fusionCre-LoxP recombinationFlow cytometry

Identifiers

PMID25900663
PMCPMC11113140
OpenAlexW2051976076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.